re: genelabs sale
contacted the company today and got a prompt reply ...
they say they don't anticipate, and have not been advised that the Genelabs Diagnostics sale will in any way affect select ... they say sale had been mooted for some time ... point also made that the involvement of a large diagnostics company like MP Biomedicals in the Genelabs Diagnostics business would be a good thing with the possibility of extra resources etc.
so, as always, if you believe in the product - and given the burnett institute's reputation there's no reason not to - then select is a bit behind in its timeline, but ready to push ahead with its various revenue generating deals.
- Forums
- ASX - By Stock
- SLT
- capital raising
capital raising, page-19
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug